Terms: = Colorectal cancer AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406
23 results:
1. Circ_0087851 suppresses colorectal cancer malignant progression through triggering miR-593-3p/bap1-mediated ferroptosis.
Huang M; Gao T; Chen X; Yi J; Zhou X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):204. PubMed ID: 38642144
[TBL] [Abstract] [Full Text] [Related]
2. Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiency.
Makino K; Ishii T; Takeda H; Saito Y; Fujiwara Y; Fujimoto M; Ito T; Wakama S; Kumagai K; Munekage F; Horie H; Tomofuji K; Oshima Y; Uebayashi EY; Kawai T; Ogiso S; Fukumitsu K; Takai A; Seno H; Hatano E
J Pathol; 2024 May; 263(1):32-46. PubMed ID: 38362598
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma.
Marmarelis ME; Wang X; Roshkovan L; Grady CB; Miura JT; Ginsberg MS; Ciunci CA; Egger J; Walker S; Cercek A; Foote MB; Litzky LA; Nash G; Haas AR; Karakousis GC; Cengel KA; Katz SI; Zauderer MG; Langer CJ; Offin M
JAMA Netw Open; 2023 Mar; 6(3):e232526. PubMed ID: 36897589
[TBL] [Abstract] [Full Text] [Related]
4. Targeting bap1 with small compound inhibitor for colon cancer treatment.
Kang M; Park SG; Lee SA; Kim S; Lee D; Shirbhate ME; Youn SY; Kim KM; Cha SS; Kwon J
Sci Rep; 2023 Feb; 13(1):2264. PubMed ID: 36754982
[TBL] [Abstract] [Full Text] [Related]
5. Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center.
Poliani L; Greco L; Barile M; Dal Buono A; Bianchi P; Basso G; Giatti V; Genuardi M; Malesci A; Laghi L;
ESMO Open; 2022 Dec; 7(6):100607. PubMed ID: 36356413
[TBL] [Abstract] [Full Text] [Related]
6. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
Puccini A; Poorman K; Catalano F; Seeber A; Goldberg RM; Salem ME; Shields AF; Berger MD; Battaglin F; Tokunaga R; Naseem M; Zhang W; Philip PA; Marshall JL; Korn WM; Lenz HJ
Oncogene; 2022 Jun; 41(26):3455-3460. PubMed ID: 35618879
[TBL] [Abstract] [Full Text] [Related]
7. Mesothelioma and colorectal cancer: Report of Four Cases with Synchronous and Metachronous Presentation.
Serio G; Pezzuto F; Fortarezza F; Marzullo A; Delfino MC; d'Amati A; Romano DE; Maniglio S; Caporusso C; Lettini T; Cavone D; Vimercati L
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269773
[TBL] [Abstract] [Full Text] [Related]
8. A nanotherapeutic strategy to overcome chemoresistance to irinotecan/7-ethyl-10-hydroxy-camptothecin in colorectal cancer.
Huang Q; Liu X; Wang H; Liu X; Zhang Q; Li K; Chen Y; Zhu Q; Shen Y; Sui M
Acta Biomater; 2022 Jan; 137():262-275. PubMed ID: 34718178
[TBL] [Abstract] [Full Text] [Related]
9. Molecular Characterization of Peritoneal Mesotheliomas.
Offin M; Yang SR; Egger J; Jayakumaran G; Spencer RS; Lopardo J; Nash GM; Cercek A; Travis WD; Kris MG; Ladanyi M; Sauter JL; Zauderer MG
J Thorac Oncol; 2022 Mar; 17(3):455-460. PubMed ID: 34648949
[TBL] [Abstract] [Full Text] [Related]
10. Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan-cancer analysis.
Shen D; Zhang J; Yuan K; Zhao J; Zhao Z; Cui L; Zhang Y; Wang G; Cai S; Bai Y; Li W; Huang X
Mol Genet Genomic Med; 2021 Aug; 9(8):e1697. PubMed ID: 34145795
[TBL] [Abstract] [Full Text] [Related]
11. bap1 promotes viability and migration of ECA109 cells through KLF5/CyclinD1/FGF-BP1.
Wang F; Luo M; Qu H; Cheng Y
FEBS Open Bio; 2021 May; 11(5):1497-1503. PubMed ID: 33529461
[TBL] [Abstract] [Full Text] [Related]
12. Roles and mechanisms of bap1 deubiquitinase in tumor suppression.
Masclef L; Ahmed O; Estavoyer B; Larrivée B; Labrecque N; Nijnik A; Affar EB
Cell Death Differ; 2021 Feb; 28(2):606-625. PubMed ID: 33462414
[TBL] [Abstract] [Full Text] [Related]
13. Primary Peritoneal Low-grade Serous Carcinoma in a Patient With Lynch Syndrome: A Case Report.
Makiuchi S; Yoshida H; Ishikawa M; Kojima N; Kanai Y; Kato T
Int J Gynecol Pathol; 2020 Jul; 39(4):327-332. PubMed ID: 31274699
[TBL] [Abstract] [Full Text] [Related]
14. Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer.
Lin PC; Yeh YM; Wu PY; Hsu KF; Chang JY; Shen MR
Sci Rep; 2019 Mar; 9(1):3931. PubMed ID: 30850667
[TBL] [Abstract] [Full Text] [Related]
15. bap1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.
Shahriyari L; Abdel-Rahman M; Cebulla C
PLoS One; 2019; 14(2):e0211507. PubMed ID: 30716094
[TBL] [Abstract] [Full Text] [Related]
16. Relationship Between Lesions in Adenomatous Polyp-Dysplasia-colorectal cancer Sequence and Neutrophil-to-Lymphocyte Ratio.
Uçmak F; Tuncel ET
Med Sci Monit; 2016 Nov; 22():4536-4541. PubMed ID: 27881836
[TBL] [Abstract] [Full Text] [Related]
17. Different prognostic roles of tumor suppressor gene bap1 in cancer: A systematic review with meta-analysis.
Luchini C; Veronese N; Yachida S; Cheng L; Nottegar A; Stubbs B; Solmi M; Capelli P; Pea A; Barbareschi M; Fassan M; Wood LD; Scarpa A
Genes Chromosomes Cancer; 2016 Oct; 55(10):741-9. PubMed ID: 27223342
[TBL] [Abstract] [Full Text] [Related]
18. Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.
Ørntoft MB; Nielsen HJ; Ørntoft TF; Andersen CL;
BMC Cancer; 2015 Oct; 15():819. PubMed ID: 26514170
[TBL] [Abstract] [Full Text] [Related]
19. POLE mutations in families predisposed to cutaneous melanoma.
Aoude LG; Heitzer E; Johansson P; Gartside M; Wadt K; Pritchard AL; Palmer JM; Symmons J; Gerdes AM; Montgomery GW; Martin NG; Tomlinson I; Kearsey S; Hayward NK
Fam Cancer; 2015 Dec; 14(4):621-8. PubMed ID: 26251183
[TBL] [Abstract] [Full Text] [Related]
20. Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.
Katoh M
Expert Rev Proteomics; 2015 Jun; 12(3):317-28. PubMed ID: 25835095
[TBL] [Abstract] [Full Text] [Related]
[Next]
